Clinical Trial Update: Glucose Variability With DPP-4 Inhibition [NA]

View source ↗

Summary

This update discusses an ongoing clinical trial evaluating glucose variability in patients with type 2 diabetes treated with a DPP-4 inhibitor. No trial phase o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DPP-4 inhibitor (class)

Snippet

Sponsor: Research Clinical Centre of the Russian Railways, JSC | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN